DBV Technologies Receives Requested Feedback from FDA on Protocol Design Elements for COMFORT Safety Studies and Reports Third Quarter 2023 Financial Results
PremiumPress ReleasesMonthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2023